Neuberger Berman Group’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Neuberger Berman Group's RAPP Position: Q3 2026 in Review
Neuberger Berman Group opened a new position in Rapport Therapeutics (RAPP) in Q3 2026: 95,805 shares worth $3.22M. The stake represents ﹤0.01% of the portfolio and ranks #1164 among its holdings.
168 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Neuberger Berman Group held 95,805 shares of Rapport Therapeutics worth $3.22M as of Q3 2026.
- Rapport Therapeutics was a new Neuberger Berman Group position in Q3 2026.
- Rapport Therapeutics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #1164 holding.
- 168 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.